hasCommonAdverseEffect
P23164
predicate
Indicates that two or more entities share at least one adverse effect that occurs in response to them.
All labels observed (3)
| Label | Occurrences |
|---|---|
| commonAdverseEffect | 326 |
| hasCommonAdverseEffect canonical | 227 |
| commonAdverseEvent | 8 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasCommonAdverseEffect
Generated description
Indicates that two or more entities share at least one adverse effect that occurs in response to them.
Sample triples (561)
| Subject | Object |
|---|---|
|
edaravone
surface form:
Edaravone
|
gait disturbance ⓘ |
|
edaravone
surface form:
Edaravone
|
headache ⓘ |
|
edaravone
surface form:
Edaravone
|
contusion ⓘ |
|
edaravone
surface form:
Edaravone
|
eczema ⓘ |
|
edaravone
surface form:
Edaravone
|
respiratory failure ⓘ |
| Tegsedi | injection site reactions via predicate surface "commonAdverseEvent" ⓘ |
| Tegsedi | nausea via predicate surface "commonAdverseEvent" ⓘ |
| Tegsedi | headache via predicate surface "commonAdverseEvent" ⓘ |
| Tegsedi | fatigue via predicate surface "commonAdverseEvent" ⓘ |
| Waylivra | injection site reactions via predicate surface "commonAdverseEffect" ⓘ |
| Waylivra | flu-like symptoms via predicate surface "commonAdverseEffect" ⓘ |
| Waylivra | nausea via predicate surface "commonAdverseEffect" ⓘ |
| Mounjaro | nausea via predicate surface "commonAdverseEffect" ⓘ |
| Mounjaro | vomiting via predicate surface "commonAdverseEffect" ⓘ |
| Mounjaro | diarrhea via predicate surface "commonAdverseEffect" ⓘ |
| Mounjaro | decreased appetite via predicate surface "commonAdverseEffect" ⓘ |
| Mounjaro | constipation via predicate surface "commonAdverseEffect" ⓘ |
| MabThera | infusion-related reactions via predicate surface "commonAdverseEffect" ⓘ |
| MabThera | infections via predicate surface "commonAdverseEffect" ⓘ |
| MabThera | neutropenia via predicate surface "commonAdverseEffect" ⓘ |
| MabThera | hypogammaglobulinemia via predicate surface "commonAdverseEffect" ⓘ |
| aflibercept | conjunctival hemorrhage via predicate surface "commonAdverseEffect" ⓘ |
| aflibercept | eye pain via predicate surface "commonAdverseEffect" ⓘ |
| aflibercept | increased intraocular pressure via predicate surface "commonAdverseEffect" ⓘ |
| aflibercept | cataract via predicate surface "commonAdverseEffect" ⓘ |
| Ixifi | infusion-related reaction ⓘ |
| Ixifi | upper respiratory tract infection ⓘ |
| Ixifi | headache ⓘ |
| apixaban | bleeding via predicate surface "commonAdverseEffect" ⓘ |
| apixaban | anemia via predicate surface "commonAdverseEffect" ⓘ |
| apixaban | nausea via predicate surface "commonAdverseEffect" ⓘ |
| dabigatran | bleeding ⓘ |
| dabigatran | gastrointestinal bleeding ⓘ |
| dabigatran | dyspepsia ⓘ |
| dabigatran | gastritis-like symptoms ⓘ |
| Epidiolex | somnolence via predicate surface "commonAdverseEffect" ⓘ |
| Epidiolex | decreased appetite via predicate surface "commonAdverseEffect" ⓘ |
| Epidiolex | diarrhea via predicate surface "commonAdverseEffect" ⓘ |
| Epidiolex | fatigue via predicate surface "commonAdverseEffect" ⓘ |
| Epidiolex | elevated liver enzymes via predicate surface "commonAdverseEffect" ⓘ |
| R-CHOP | myelosuppression via predicate surface "commonAdverseEffect" ⓘ |
| R-CHOP | nausea and vomiting via predicate surface "commonAdverseEffect" ⓘ |
| R-CHOP | alopecia via predicate surface "commonAdverseEffect" ⓘ |
| R-CHOP | peripheral neuropathy via predicate surface "commonAdverseEffect" ⓘ |
| R-CHOP | cardiotoxicity from doxorubicin via predicate surface "commonAdverseEffect" ⓘ |
| R-CHOP | immunosuppression and infection risk via predicate surface "commonAdverseEffect" ⓘ |
| Ruxience | infusion-related reactions ⓘ |
| Ruxience | infections ⓘ |
| Ruxience | neutropenia ⓘ |
| Ruxience | hypogammaglobulinemia ⓘ |